Low-Dose Acyclovir Reduces the Reactivation of Herpes Simplex and Varicella Zoster Viruses After Allogeneic Stem Cell Transplantation
Sorana G Ursu, Mohammad M Alhousani, Gina Patrus, Salman Fazal · 2024
Read Low-Dose Acyclovir Reduces the Reactivation of Herpes Simplex and Varicella Zoster Viruses After Allogeneic Stem Cell Transplantation by Sorana G Ursu, Mohammad M Alhousani, Gina Patrus, Salman Fazal (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11703650.txt.
Description
Sorana Ursu and co-authors check whether a low dose of the antiviral acyclovir can stop herpes viruses waking up after a donor stem cell transplant. Their 2024 study reviews charts at one center for transplants done between 2016 and 2023. Such transplants leave patients open to the herpes simplex and shingles viruses, and centers differ widely in the preventive dose they give.
Patients here took a modest dose by mouth twice a day, starting before the transplant and running for two years, longer while immune-suppressing drugs continued. The team counted how many still had a viral flare, when flares came, and what side effects or hospital stays followed. The aim is a gentler dose that still protects.
Catalog record
| CREATOR | Sorana G Ursu, Mohammad M Alhousani, Gina Patrus, Salman Fazal |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |